13 results found.

Pancreatic Diseases, Pancreatic Neoplasms, or Pancreatitis Clinical Trial using No interventions, this is an observational study

Aalborg Universityhospital - Recruiting 18 years or older.
- Cell-free DNA Promoter Hypermethylation in Plasma From Patients With Pancreatic Adenocarcinoma, Compared to Patients With Pancreatitis and Pancreatitis and Patients Screened for, But Not Having Pancreatic Adenocarcinoma.'.
No interventions, this is an observational study

Pancreatic Neoplasms Clinical Trial using Oxaliplatin; Irinotecan; Leucovorin; Fluorouracil; laboratory biomarker analysis; flow cytometry; immunohistochemistry staining method; pharmacological study; PF-04136309

Washington University School of Medicine - Recruiting 18 years or older.
- Phase IB Study of FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Oxaliplatin; Irinotecan; Leucovorin; Fluorouracil; laboratory biomarker analysis; flow cytometry; immunohistochemistry staining method; pharmacological study; PF-04136309

Neoplasms, Pancreas Clinical Trial using cancer stem cell vaccine

Fuda Cancer Hospital, Guangzhou - Recruiting 18 years to 75 years.
- Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Pancreas.
cancer stem cell vaccine

Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Can Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites..

Lung or Prostatic Neoplasms, Colorectal or Kidney Neoplasms, Panc Clinical Trial using NK cells +CliniMACs CD3 and CD56 systems

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK TRAIL Cytotoxicity With Bortezomib.
NK cells +CliniMACs CD3 and CD56 systems

Adenocarcinoma, or Pancreatic Neoplasms Clinical Trial using X-82; Everolimus

Washington University School of Medicine - Recruiting 18 years or older.
- A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors.
X-82; Everolimus

Melanoma, Breast Neoplasms, Lobular Carcinoma, Triple-negative Br Clinical Trial using LGK974

Novartis - Recruiting 18 years or older.
- A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands.
LGK974

Pancreatic Neoplasms Clinical Trial using Ascorbate; Gemcitabine; Radiation therapy

University of Iowa - Recruiting 18 years or older.
- Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I.
Ascorbate; Gemcitabine; Radiation therapy

Breast Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Pancre Clinical Trial using ý1ýPb-TCMC-Trastuzumab; trastuzumab

Areva Med LLC - Recruiting 19 years or older.
- Phase I Trial of Intraperitoneal ý1ýPb-TCMC-Trastuzumab for HER-2 Expressing Malignancy.
ý1ýPb-TCMC-Trastuzumab; trastuzumab

Pancreatic Neoplasms, Biliary Tract Neoplasms, Pancreatitis, Chro Clinical Trial using pancreaticojejunostomy

Thomas Jefferson University - Recruiting 18 years or older.
- A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy.
pancreaticojejunostomy

Pancreatic Neoplasms Clinical Trial using 22 gauge ProCore needle biopsy; 25 gauge ProCore needle biopsy

Samsung Medical Center - Recruiting 18 years or older.
- Endoscopic Ultrasound-guided Fine Needle Tissue Acquisition With 22- and 25-gauge ProCore Needle in Solid Pancreatic and Peripancreatic Masses: A Prospective Comparative Study.
22 gauge ProCore needle biopsy; 25 gauge ProCore needle biopsy

Pancreatic Neoplasms, Biliary Tract Neoplasms, Pancreatitis, Chro Clinical Trial using pancreaticojejunostomy

Fudan University - Recruiting 18 years to 80 years.
- A Prospective Randomized Clinical Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy: Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy.
pancreaticojejunostomy

Pancreas Neoplasms Clinical Trial using Docetaxel; Oxaliplatin

University of Ulm - Recruiting 18 years or older.
- Phase II Study: Docetaxel Plus Oxaliplatin as Second-line Therapy in Patients With Advanced Metastatic Pancreatic Cancer.
Docetaxel; Oxaliplatin